Free Trial

Amprius Technologies (AMPX) Financials

Amprius Technologies logo
$21.72 +0.32 (+1.51%)
As of 12:04 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Amprius Technologies

Annual Income Statements for Amprius Technologies

This table shows Amprius Technologies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-9.90 -17 -37 -45 -44
Consolidated Net Income / (Loss)
-9.90 -17 -37 -45 -44
Net Income / (Loss) Continuing Operations
-9.90 -17 -37 -45 -44
Total Pre-Tax Income
-9.90 -17 -37 -45 -44
Total Operating Income
-11 -18 -39 -46 -47
Total Gross Profit
-4.33 -5.65 -15 -18 8.26
Total Revenue
2.77 4.41 9.05 24 73
Operating Revenue
2.77 4.41 9.05 24 73
Total Cost of Revenue
7.10 10 24 42 65
Operating Cost of Revenue
7.10 10 24 42 65
Total Operating Expenses
6.29 12 24 28 55
Selling, General & Admin Expense
4.84 10 20 19 23
Research & Development Expense
1.45 2.03 3.68 7.34 9.43
Restructuring Charge
- - - 1.86 23
Total Other Income / (Expense), net
0.73 0.71 1.93 1.59 2.62
Interest & Investment Income
-0.02 0.71 2.51 1.59 2.62
Basic Earnings per Share
($0.15) ($0.24) ($0.43) ($0.45) ($0.35)
Weighted Average Basic Shares Outstanding
65.76M 71.34M 86.20M 101.87M 124.64M
Diluted Earnings per Share
($0.15) ($0.24) ($0.43) ($0.45) ($0.35)
Weighted Average Diluted Shares Outstanding
65.76M 71.34M 86.20M 101.87M 124.64M
Weighted Average Basic & Diluted Shares Outstanding
- 84.63M 91.60M 117.93M 137.02M

Quarterly Income Statements for Amprius Technologies

This table shows Amprius Technologies' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-9.45 -8.49 -9.73 -9.89 -13 -11 -11 -9.37 -6.37 -3.89 -24
Consolidated Net Income / (Loss)
-9.45 -8.49 -9.73 -9.89 -13 -11 -11 -9.37 -6.37 -3.89 -24
Net Income / (Loss) Continuing Operations
-9.45 -8.49 -9.73 -9.89 -13 -11 -11 -9.37 -6.37 -3.89 -24
Total Pre-Tax Income
-9.45 -8.49 -9.73 -9.89 -13 -11 -11 -9.37 -6.37 -3.89 -24
Total Operating Income
-10 -9.13 -9.74 -10 -13 -11 -12 -9.67 -6.81 -4.69 -25
Total Gross Profit
-3.03 -4.25 -3.88 -4.45 -6.53 -5.10 -2.25 -2.36 1.34 3.32 5.97
Total Revenue
1.63 2.80 3.94 2.34 3.35 7.86 11 11 15 21 25
Operating Revenue
1.63 2.80 3.94 2.34 3.35 7.86 11 11 15 21 25
Total Cost of Revenue
4.66 7.05 7.82 6.78 9.88 13 13 14 14 18 19
Operating Cost of Revenue
4.66 7.05 7.82 6.78 9.88 13 13 14 14 18 19
Total Operating Expenses
7.05 4.88 5.87 5.87 6.40 6.15 9.51 7.31 8.15 8.01 31
Selling, General & Admin Expense
6.28 4.07 4.58 4.29 4.74 4.34 5.36 5.31 5.99 5.50 6.16
Research & Development Expense
0.77 0.82 1.29 1.58 1.66 1.82 2.28 2.00 2.16 2.51 2.76
Total Other Income / (Expense), net
0.64 0.64 0.01 0.43 0.42 0.40 0.34 0.30 0.44 0.80 1.08
Basic Earnings per Share
($0.11) ($0.10) ($0.11) ($0.11) ($0.13) ($0.10) ($0.11) ($0.08) ($0.05) ($0.03) ($0.19)
Weighted Average Basic Shares Outstanding
85.22M 86.35M 86.20M 90.03M 97.05M 110.41M 101.87M 117.97M 121.78M 126.63M 124.64M
Diluted Earnings per Share
($0.11) ($0.10) ($0.11) ($0.11) ($0.13) ($0.10) ($0.11) ($0.08) ($0.05) ($0.03) ($0.19)
Weighted Average Diluted Shares Outstanding
85.22M 86.35M 86.20M 90.03M 97.05M 110.41M 101.87M 117.97M 121.78M 126.63M 124.64M
Weighted Average Basic & Diluted Shares Outstanding
86.27M 88.40M 91.60M 94.47M 111.05M 105.84M 117.93M 120.55M 125.08M 130.48M 137.02M

Annual Cash Flow Statements for Amprius Technologies

This table details how cash moves in and out of Amprius Technologies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
11 58 -24 11 36
Net Cash From Operating Activities
-8.02 -14 -26 -33 -31
Net Cash From Continuing Operating Activities
-8.02 -14 -26 -33 -31
Net Income / (Loss) Continuing Operations
-9.90 -17 -37 -45 -44
Consolidated Net Income / (Loss)
-9.90 -17 -37 -45 -44
Depreciation Expense
1.44 1.54 1.81 3.81 4.37
Amortization Expense
0.55 1.59 3.06 6.39 5.14
Non-Cash Adjustments To Reconcile Net Income
1.89 3.27 5.61 9.21 30
Changes in Operating Assets and Liabilities, net
-2.00 -2.94 0.75 -8.08 -27
Net Cash From Investing Activities
-0.61 -1.48 -18 -3.21 -4.40
Net Cash From Continuing Investing Activities
-0.61 -1.48 -18 -3.21 -4.40
Purchase of Property, Plant & Equipment
-0.61 -1.48 -18 -3.21 -4.40
Net Cash From Financing Activities
20 74 19 47 71
Net Cash From Continuing Financing Activities
20 74 19 47 71
Repurchase of Common Equity
0.00 -0.33 -0.60 -0.76 0.00
Issuance of Common Equity
0.00 78 19 33 64
Other Financing Activities, net
20 -3.93 0.31 14 7.37
Effect of Exchange Rate Changes
- - - 0.00 0.00

Quarterly Cash Flow Statements for Amprius Technologies

This table details how cash moves in and out of Amprius Technologies' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Net Change in Cash & Equivalents
0.82 -12 -7.64 -5.52 7.40 -11 20 -6.53 5.78 19 17
Net Cash From Operating Activities
-5.58 -8.68 -4.80 -9.78 -7.96 -9.53 -6.09 -14 -4.27 -9.25 -3.50
Net Cash From Continuing Operating Activities
-5.58 -8.68 -4.80 -9.78 -7.96 -9.53 -6.09 -14 -4.27 -9.25 -3.50
Net Income / (Loss) Continuing Operations
-9.45 -8.49 -9.73 -9.89 -13 -11 -11 -9.37 -6.37 -3.89 -24
Consolidated Net Income / (Loss)
-9.45 -8.49 -9.73 -9.89 -13 -11 -11 -9.37 -6.37 -3.89 -24
Depreciation Expense
0.44 0.46 0.49 1.02 1.04 0.86 0.89 0.94 1.02 1.18 1.22
Amortization Expense
0.07 1.48 1.18 1.29 - 5.10 1.29 1.29 1.29 1.29 1.29
Non-Cash Adjustments To Reconcile Net Income
1.43 0.61 2.84 1.25 3.23 -0.85 4.30 2.10 2.45 1.39 24
Changes in Operating Assets and Liabilities, net
1.93 -2.74 0.43 -3.44 0.30 -3.80 -1.14 -9.08 -2.65 -9.21 -6.07
Net Cash From Investing Activities
-1.73 -8.93 -5.75 -3.90 -1.61 -1.33 3.63 -0.91 -0.72 -0.41 -2.36
Net Cash From Continuing Investing Activities
-1.73 -8.93 -5.75 -3.90 -1.61 -1.33 3.63 -0.91 -0.72 -0.41 -2.36
Purchase of Property, Plant & Equipment
-1.73 -8.93 -5.75 -3.90 -1.61 -1.33 3.63 -0.91 -0.72 -0.41 -2.36
Net Cash From Financing Activities
8.13 6.00 2.92 8.16 17 -0.54 23 8.51 11 29 23
Net Cash From Continuing Financing Activities
8.13 6.00 2.92 8.16 17 -0.54 23 8.51 11 29 23
Issuance of Common Equity
8.12 6.04 2.92 8.13 2.73 - 23 8.46 9.74 26 20
Other Financing Activities, net
0.00 0.11 0.20 0.03 14 - 0.01 0.05 1.02 2.83 3.47
Effect of Exchange Rate Changes
- - - 0.00 - - - -0.00 -0.00 0.00 0.01

Annual Balance Sheets for Amprius Technologies

This table presents Amprius Technologies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
19 83 108 121 157
Total Current Assets
14 75 51 69 126
Cash & Equivalents
11 70 46 55 90
Accounts Receivable
0.26 0.69 1.27 5.58 24
Inventories, net
0.50 0.50 0.73 6.57 6.74
Prepaid Expenses
0.16 2.39 1.99 1.45 5.50
Plant, Property, & Equipment, net
4.21 4.24 22 17 9.68
Total Noncurrent Assets
0.14 3.76 35 35 21
Other Noncurrent Operating Assets
0.14 3.76 35 35 21
Total Liabilities & Shareholders' Equity
19 83 108 121 157
Total Liabilities
4.67 10 48 52 53
Total Current Liabilities
4.17 6.92 13 17 18
Accounts Payable
1.81 3.74 8.94 12 10
Current Deferred Revenue
2.36 2.66 3.43 1.64 2.84
Other Current Liabilities
0.00 0.52 1.09 3.32 4.67
Total Noncurrent Liabilities
0.50 3.22 34 34 35
Other Noncurrent Operating Liabilities
0.00 2.50 34 34 35
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
14 73 60 69 104
Total Preferred & Common Equity
14 73 60 69 104
Preferred Stock
- 0.00 0.00 0.00 0.00
Total Common Equity
14 73 60 69 104
Common Stock
89 166 189 244 322
Retained Earnings
-75 -93 -130 -174 -218
Accumulated Other Comprehensive Income / (Loss)
- - - 0.00 0.00

Quarterly Balance Sheets for Amprius Technologies

This table presents Amprius Technologies' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025
Total Assets
87 84 87 87 105 113 104 118 123 156
Total Current Assets
78 70 71 61 46 53 45 66 72 107
Cash & Equivalents
74 64 65 53 39 46 35 48 54 73
Accounts Receivable
0.78 0.56 1.13 1.89 1.44 1.74 4.59 10 11 22
Inventories, net
0.50 0.85 0.50 0.49 0.86 1.53 2.66 4.00 4.34 4.68
Prepaid Expenses
2.32 1.84 1.48 2.74 3.35 2.17 2.64 3.31 2.56 6.88
Plant, Property, & Equipment, net
3.82 4.95 6.90 17 23 24 24 18 17 16
Total Noncurrent Assets
4.86 9.10 9.03 8.55 36 36 35 34 34 33
Other Noncurrent Operating Assets
4.86 9.10 9.03 8.55 36 36 35 34 34 33
Total Liabilities & Shareholders' Equity
87 84 87 87 105 113 104 118 123 156
Total Liabilities
11 17 20 21 45 48 48 48 46 53
Total Current Liabilities
6.14 8.88 12 14 9.76 13 13 14 12 16
Accounts Payable
4.82 4.69 7.74 9.23 5.42 7.76 9.13 8.55 7.81 12
Current Deferred Revenue
0.80 3.14 3.20 3.57 3.24 3.15 1.82 1.78 0.84 0.71
Other Current Liabilities
0.52 1.06 1.07 1.08 1.10 1.92 2.05 3.64 3.43 3.22
Total Noncurrent Liabilities
4.36 8.03 7.94 6.98 35 35 35 34 34 37
Other Noncurrent Operating Liabilities
2.58 7.13 7.00 6.87 35 35 35 34 34 37
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
76 67 67 66 60 65 56 70 77 103
Total Preferred & Common Equity
76 67 67 66 60 65 56 70 77 103
Preferred Stock
- - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
76 67 67 66 60 65 56 70 77 103
Common Stock
163 169 178 186 199 217 219 254 267 297
Retained Earnings
-87 -102 -111 -120 -140 -152 -163 -184 -190 -194
Accumulated Other Comprehensive Income / (Loss)
- - - - - - - -0.00 -0.01 -0.00

Annual Metrics And Ratios for Amprius Technologies

This table displays calculated financial ratios and metrics derived from Amprius Technologies' official financial filings.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
- - - - 130,483,838.00
DEI Adjusted Shares Outstanding
- - - - 130,483,838.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - -0.34
Growth Metrics
- - - - -
Profitability Metrics
- - - - -
Net Operating Profit after Tax (NOPAT)
-7.44 -13 -27 -32 -33
Return On Investment Capital (ROIC_SIMPLE)
- - -45.31% -46.61% -31.45%
Earnings before Interest and Taxes (EBIT)
-11 -18 -39 -46 -47
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-8.63 -15 -34 -36 -37
Valuation Ratios
- - - - -
Leverage & Solvency
- - - - -
Liquidity Ratios
- - - - -
Cash Flow Metrics
- - - - -
Free Cash Flow to Firm (FCFF)
0.00 -14 -38 -33 -32
Efficiency Ratios
- - - - -
Capital & Investment Metrics
- - - - -
Invested Capital
2.37 3.34 14 14 13
Increase / (Decrease) in Invested Capital
0.00 0.97 11 0.28 -0.97
Book Value per Share
$0.21 $0.86 $0.68 $0.66 $0.80
Tangible Book Value per Share
$0.21 $0.86 $0.68 $0.66 $0.80
Total Capital
14 73 60 69 104
Total Debt
0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00
Net Debt
-11 -70 -46 -55 -90
Capital Expenditures (CapEx)
0.61 1.48 18 3.21 4.40
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-1.48 -1.44 -8.70 -3.60 18
Debt-free Net Working Capital (DFNWC)
10 68 37 52 109
Net Working Capital (NWC)
10 68 37 52 109
Net Nonoperating Expense (NNE)
2.46 4.70 9.68 12 11
Net Nonoperating Obligations (NNO)
-11 -70 -46 -55 -90
Total Depreciation and Amortization (D&A)
1.99 3.12 4.86 10 9.51
Earnings Adjustments
- - - - -
Adjusted Basic Earnings per Share
$0.00 ($0.24) ($0.43) ($0.45) ($0.35)
Adjusted Weighted Average Basic Shares Outstanding
0.00 71.34M 86.20M 101.87M 124.64M
Adjusted Diluted Earnings per Share
$0.00 ($0.24) ($0.43) ($0.45) ($0.35)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 71.34M 86.20M 101.87M 124.64M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 84.63M 91.60M 117.93M 137.02M
Normalized Net Operating Profit after Tax (NOPAT)
-7.44 -13 -27 -31 -17
Debt Service Ratios
- - - - -
Payout Ratios
- - - - -

Quarterly Metrics And Ratios for Amprius Technologies

This table displays calculated financial ratios and metrics derived from Amprius Technologies' official financial filings.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
DEI Shares Outstanding
- - - - - - - - - - 130,483,838.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 130,483,838.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - -0.19
Growth Metrics
- - - - - - - - - - -
Profitability Metrics
- - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)
-7.06 -6.39 -6.82 -7.22 -9.05 -7.88 -8.23 -6.77 -4.77 -3.28 -18
Return On Investment Capital (ROIC_SIMPLE)
- - -11.41% - - - -11.85% -9.62% -6.22% -3.18% -17.17%
Earnings before Interest and Taxes (EBIT)
-10 -9.13 -9.74 -10 -13 -11 -12 -9.67 -6.81 -4.69 -25
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-9.58 -7.19 -8.08 -9.30 -12 -5.29 -9.58 -7.44 -4.51 -2.23 -23
Valuation Ratios
- - - - - - - - - - -
Leverage & Solvency
- - - - - - - - - - -
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
201 -17 -18 -25 -26 -16 -8.51 -7.86 -8.55 -12 -17
Efficiency Ratios
- - - - - - - - - - -
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1.68 12 14 21 19 21 14 22 22 30 13
Increase / (Decrease) in Invested Capital
-208 10 11 18 17 8.59 0.28 1.09 3.78 9.01 -0.97
Book Value per Share
$0.78 $0.76 $0.68 $0.65 $0.69 $0.50 $0.66 $0.60 $0.64 $0.83 $0.80
Tangible Book Value per Share
$0.78 $0.76 $0.68 $0.65 $0.69 $0.50 $0.66 $0.60 $0.64 $0.83 $0.80
Total Capital
67 66 60 60 65 56 69 70 77 103 104
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-65 -53 -46 -39 -46 -35 -55 -48 -54 -73 -90
Capital Expenditures (CapEx)
1.73 8.93 5.75 3.90 1.61 1.33 -3.63 0.91 0.72 0.41 2.36
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-6.32 -5.88 -8.70 -3.18 -6.23 -3.11 -3.60 3.75 5.59 17 18
Debt-free Net Working Capital (DFNWC)
59 48 37 36 40 32 52 52 60 91 109
Net Working Capital (NWC)
59 48 37 36 40 32 52 52 60 91 109
Net Nonoperating Expense (NNE)
2.39 2.10 2.91 2.66 3.46 2.97 3.19 2.60 1.60 0.61 6.56
Net Nonoperating Obligations (NNO)
-65 -53 -46 -39 -46 -35 -55 -48 -54 -73 -90
Total Depreciation and Amortization (D&A)
0.51 1.94 1.66 1.02 1.04 5.97 2.18 2.23 2.30 2.47 2.51
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.11) ($0.10) ($0.11) ($0.11) ($0.13) ($0.10) ($0.11) ($0.08) ($0.05) ($0.03) ($0.19)
Adjusted Weighted Average Basic Shares Outstanding
85.22M 86.35M 86.20M 90.03M 97.05M 110.41M 101.87M 117.97M 121.78M 126.63M 124.64M
Adjusted Diluted Earnings per Share
($0.11) ($0.10) ($0.11) ($0.11) ($0.13) ($0.10) ($0.11) ($0.08) ($0.05) ($0.03) ($0.19)
Adjusted Weighted Average Diluted Shares Outstanding
85.22M 86.35M 86.20M 90.03M 97.05M 110.41M 101.87M 117.97M 121.78M 126.63M 124.64M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
86.27M 88.40M 91.60M 94.47M 111.05M 105.84M 117.93M 120.55M 125.08M 130.48M 137.02M
Normalized Net Operating Profit after Tax (NOPAT)
-7.06 -6.39 -6.82 -7.22 -9.05 -7.88 -8.23 -6.77 -4.77 -3.28 -18
Debt Service Ratios
- - - - - - - - - - -
Payout Ratios
- - - - - - - - - - -

Financials Breakdown Chart

Key Financial Trends

Amprius Technologies (AMPX) shows a clear revenue recovery in 2025, a notable gross margin improvement in Q4, and improved liquidity driven by financing activity. However, the company remains unprofitable with ongoing cash burn from operations and a large accumulated deficit. Here are the 10 most important takeaways from the last four years of quarterly statements:

  • Revenue growth: total revenue rose through 2025, from about 11.28 million in Q1 2025 to about 25.23 million in Q4 2025 (Q2 2025: 15.07M; Q3 2025: 21.43M).
  • Gross margin improvement: Q4 2025 gross margin reached about 23.7% (5.97M gross profit on 25.23M revenue), a meaningful improvement from earlier 2025 quarters (Q3 2025 ~15.5%, Q2 2025 ~8.9%).
  • Liquidity growth: cash and equivalents rose to about 73.2 million by Q3 2025, up from roughly 54.2 million in Q2 2025 and 48.4 million in Q1 2025, signaling better near‑term liquidity.
  • Financing support: net cash from financing activities was strong in 2025 (Q3 2025 around +28.7M; Q4 2025 around +23.1M), helped by equity issuance (Q4 2025 issuance of common equity about 19.6M).
  • Capital cushion: Total Common Equity was around 103.2 million in Q3 2025, indicating a solid capitalization base to support ongoing operations.
  • Profits still elusive: 2025 remains unprofitable, with net income of about -3.89 million in Q3 2025 and -24.39 million in Q4 2025 (quarterly net losses vary by period).
  • Cash burn from operations: negative net cash from operating activities in every 2025 quarter (Q4 2025 around -3.50M; Q3 2025 around -9.25M; Q2 2025 around -4.27M; Q1 2025 around -14.13M).
  • Elevated expense base: SG&A and R&D remain high relative to revenue (Q4 2025 SG&A about 6.16M; R&D about 2.76M on 25.23M of revenue), continuing to pressure margins.
  • Retained earnings deficit: negative retained earnings around -193.97 million by Q3 2025, underscoring decades of losses and a long path to profitability.
  • Dilution risk: substantial equity issuances in 2025 increased shares outstanding and may dilute existing shareholders, despite the near‑term liquidity benefits.
05/06/26 10:37 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Amprius Technologies' Financials

When does Amprius Technologies' fiscal year end?

According to the most recent income statement we have on file, Amprius Technologies' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

How has Amprius Technologies' net income changed over the last 4 years?

Amprius Technologies' net income appears to be on an upward trend, with a most recent value of -$44.02 million in 2025, rising from -$9.90 million in 2021. The previous period was -$44.67 million in 2024. Find out what analysts predict for Amprius Technologies in the coming months.

What is Amprius Technologies' operating income?
Amprius Technologies' total operating income in 2025 was -$46.65 million, based on the following breakdown:
  • Total Gross Profit: $8.26 million
  • Total Operating Expenses: $54.91 million
How has Amprius Technologies' revenue changed over the last 4 years?

Over the last 4 years, Amprius Technologies' total revenue changed from $2.77 million in 2021 to $73.01 million in 2025, a change of 2,533.9%.

How much debt does Amprius Technologies have?

Amprius Technologies' total liabilities were at $53.08 million at the end of 2025, a 2.8% increase from 2024, and a 1,036.8% increase since 2021.

How much cash does Amprius Technologies have?

In the past 4 years, Amprius Technologies' cash and equivalents has ranged from $11.49 million in 2021 to $90.47 million in 2025, and is currently $90.47 million as of their latest financial filing in 2025.

How has Amprius Technologies' book value per share changed over the last 4 years?

Over the last 4 years, Amprius Technologies' book value per share changed from 0.21 in 2021 to 0.80 in 2025, a change of 277.6%.



Financial statements for NYSE:AMPX last updated on 3/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners